In ancient times, before the advent of ICT (Information & Communication Technology), good mechanicals used to check manually and carefully each area of the engine, testing structure and function, in order to discover the location of the fault, or the danger, perhaps previously reported by strange noises.
The Brain Sensor acts like the ‘check engine” light, which illuminates whenever there is a problem, a disorder, even very initial or silent, as Inheried Real Risks,in the human body which leads to the activation of one or more centers of the PNEI system, and limbic region.
Quantum Biophysical Semeiotics [1,2] provide tools for Brain Bedside Sensor Evaluation (BSBE) to see if the “check” light of a subject is turned on or off. In particular, micro-vascular wall dynamics must be observed according to Clinical Microangiology [3].
In the brain, the neural centers of the SST-RH and epiphysis represent the main site of regulation of the human body’s defense against harmful agents both internal (metabolic changes, renal excretory organs, etc..) and external (viruses, bacteria, toxic, etc..) one, and, i.e., if they are functionally/structurally altered this is the basis of Oncological Terrain – OT [4].
The null hypothesis that has been agreed to forge is as follows. For instance, if a single cell degenerates, becoming a no-social element, the neural centers responsible for the protection of anti-neoplastic immediately feel the danger, and they are activated by increasing the means of defense, cellular and not cellular, until healing in the healthy subject occurs.
Similarly, when an agent virus attacks the human body, the Tissue Micro-vascular Unit diagram [5] of the digital tip, starting from the first stage, changes, and we immediately realize that the organism defense centers are stimulated, more or less intensely, increasing vasomotility and vasomotion of local microvessels, according to Angiobiopathy theory [6].
In addition, the limbic system, under all the conditions of change in the way of being and functioning of a tissue – glandular, with outer secretion, muscular, etc. – above referred as example – reacts simultaneously with the organism defense neuronal centers (7-18).
Then, continuing this assessment, when micro-vascular systole begins, we stimulate, with the though, according to Psychokinetic Diagnostics [12], or with the help of the patient, the tissue to be examined.
In healthy subject, vasomotility and subsequent vasomotion continue unchanged in the same way, showing a physiological behavior.
In case of micro-circulatory activation, type I associated, the duration of the first reflex (first phase, i.e., diastole) increases to 6.5 seconds , followed by a pause (namely the systole) of 5.5 seconds, before the next fluctuation, confirming a sustained period of 12 seconds (6.5 sec. + 6.5 sec .).
The ureteral upper third Auscultatory Percussion (and similarly that of the lower one), with a “light” pressure on the trigger points of the PNEI system centers, allows to check at any time if the Brain Sensor is activated or not, assessing the degree of this activation.
This method is called ‘Brain Sensor Bedside Evaluation’ – BSBE.
BSBE significances are as follows:
- In case of a-specific microcirculation at rest 6+6 (Figure 2) the Brain Sensor is not activated, the light is not on, indicating physiological health condition;
- In case of a-specific micro-circulatory activation 6.5+5.5 (Figure 3) the Brain Sensor is activated, the “check” light is on, indicating that something is wrong in the body, a-specific in nature, but not oncological one: we term it negative Gandolfo’s Sign in case of Oncological Terrain [see last chapter];
- In case of a-specific micro-circulatory activation of at least 7 the Brain Sensor is activated, the “check” light is on: positive Gandolfo’s Sign in case of Oncological Terrain and Inherited Real Risk of cancer or very beginning clinical stage of cancer [see last chapter].
In the case of activated Brain Sensor – cases 2) and 3) – one or more neural centers responsible for the PNEI and limbic[1] systems are at work, i.e., there is a suffering in some cells of one or more biological systems, a disease in progress or impending, which is addressed and opposed by the defense centers.
At this point, the physicians expert of the QBS, check the meaning of the ‘light on’ of the Brain Sensor; they will check exactly where the problem lies, i.e., the causes of initial and/or silent disorders.
Cerebellar Brian Sensors.
In health, the digital ressure of small intensity (about 300 dyne /cm 2), applied upon di superior cerebellar convolution, according to Psychokinetid Diagnostic (12), brings about the Gastric Aspecific Reflex after a Latency Time of 8 sec. Reflex duratio is ❤ sec. – sec. <
On the contrary, in patients with activated limbic system, the Reflex appears after 7 sec. or less, according to the underlyining disorder seriousness, and lasts over 4 seconds.
From the microvascular point of view, there is Activated Microcirculation type II, dyssociated.
References
- Stagnaro-Neri M., Stagnaro S. Introduzione alla Semeiotica Biofisica. Il Terreno Oncologico. Travel Factory, Roma, 2004. http://www.travelfactory.it/semeiotica_biofisica.htm
- Sergio Stagnaro. Quantum biophysical semeiotics. NeuroQuantology | September 2011 | Vol 9 | Issue 3 | Page 459‐467.http://www.neuroquantology.com/index.php/journal/issue/current/showToc
- Stagnaro S. – Introduzione alla Microangiologia Clinica – Journal of Quantum Biophysical Semeiotics . http://www.sisbq.org/uploads/5/6/8/7/5687930/mc_intro.pdf , 2011 http://www.semeioticabiofisica.it/microangiologia/common_eng.htm
- Caramel S. Stagnaro S. The role of mitochondria and mit-DNA in oncogenesis. from Quantum Biosystems. 2(1) 250-281, 2010 http://www.quantumbiosystems.org/admin/files/QBS%202(1)%20250-281.pdf
- Stagnaro S. Diabetic Constitution – Cyberlectures Indmedica – http://cyberlectures.indmedica.com/show/60/4/Diabetic_Constitution
- Stagnaro S. CAD Inherited Real Risk: Nosography and Therapy. The Concept of Angiobiopathy. www.shiphu. 11 March, 2010
- Stagnaro S. Reale Rischio Semeiotico Biofisico. I Dispositivi Endoarteriolari di Blocco neoformati, patologici, tipo I, sottotipo a) oncologico, e b) aspecifico. Ediz. Travel Factory, www.travelfactory.it, Roma, 2009
- Stagnaro S. Clinical Microangiology. Auscultarory Percussion of Ureter. Technical pages and Practical Applications. www.semeioticabiofisica.it _ English Version
- Stagnaro S., Auscultatory Percussion Therapeutic Monitoring and Cerebral Dominance in Rheumatology. 2nd World Congress of Inflammation, Antirheumatics, analgesics, immunomodulators. Abstracts, A. Book 1, pg. 116, March 19-22, Montecarlo, 1986
- Stagnaro-Neri M., Stagnaro S., Auscultatory Percussion Evaluation of Arterio-venous Anastomoses Dysfunction in early Arteriosclerosis. Acta Med. Medit. 5, 141, 1989
- Stagnaro S., Caramel S. Clinical QBS Diagnosis and Primary Prevention of Brain Disorder ‘Inherited Real Risk’ and Alzheimer Disease, JOQBS, 2011 http://www.sisbq.org/uploads/5/6/8/7/5687930/alzheimer_primaryprevention.pdf
- Stagnaro S., Caramel S. Diagnostic Psychokinetics, JOQBS, 2010
- Stagnaro S. Quantum Biophysical Semeiotics training course, SISBQ, http://www.sisbq.org/qbs-training-course.html , 2011
- Stagnaro S., Stagnaro-Neri M., Le Costituzioni Semeiotico-Biofisiche. Strumento clinico fondamentale per la prevenzione primaria e la definizione della Single Patient Based Medicine. Travel Factory, Roma, 2004
- Stagnaro S. Middle Ages of today’s Medicine, Overlooking Quantum-Biophysical-Semeiotic Constitutions and Related Inherited Real Risk. http://sciphu.com November 4, 2008. http://sciphu.com/2008/11/meadle-ages-of-todays-medicine.html
- Caramel S. Primary Prevention of Type 2 Diabetes Mellitus, JOQBS, 2010 http://www.sisbq.org/uploads/5/6/8/7/5687930/t2dm_caramel.pdf
- Stagnaro S. New Renaissance in Medicine. Type 2 Diabetes Mellitus Primary Prevention. http://www.sisbq.org/atti-del-primo-convegno.html, 16 November, 2010; http://www.sisbq.org/uploads/5/6/8/7/5687930/report_stagnaro.pdf
- Stagnaro S. A clinical efficacious maneouvre, reliable in bed-side diagnosing coronary artery disease, even initial or silent, as well as “heart coronary risk”. 3rd Virtual International Congress of Cardiology, FAC,2003,http://www.fac.org.ar/tcvc/marcoesp/marcos.htm